From Bench to Bedside—The Bad Berka Experience With First-in-Human Studies-Reference-Cited by-同舟云学术

From Bench to Bedside—The Bad Berka Experience With First-in-Human Studies

Published:2019-09 Issue:5 Volume:49 Page:422-437
ISSN:0001-2998
Container-title:Seminars in Nuclear Medicine
language:en
Short-container-title:Seminars in Nuclear Medicine

Author:

Zhang Jingjing,Singh Aviral,Kulkarni Harshad R.,Schuchardt Christiane,Müller Dirk,Wester Hans-J.,Maina Theodosia,Rösch Frank,van der Meulen Nicholas P.,Müller Cristina,Mäcke Helmut,Baum Richard P.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference90 articles.

1. Peptides and receptors in image-guided therapy: theranostics for neuroendocrine neoplasms;Baum;Semin Nucl Med,2012

2. Phase 3 trial of (177)Lu-Dotatate for midgut neuroendocrine tumors;Strosberg;N Engl J Med,2017

4. Results and adverse events of personalized peptide receptor radionuclide therapy with (90)yttrium and (177)lutetium in 1048 patients with neuroendocrine neoplasms;Baum;Oncotarget,2018

5. A new automated NaCl based robust method for routine production of gallium-68 labeled peptides;Schultz;Appl Radiat Isot,2013

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiolabeled Somatostatin Analogs for Cancer Imaging;Seminars in Nuclear Medicine;2024-08

2. Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues;International Journal of Molecular Sciences;2024-05-29

3. [68Ga]Ga-FAPI-46 synthesis on a GAIA® module system: Thorough study of the automated radiolabeling reaction conditions;Applied Radiation and Isotopes;2024-04

4. Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review;Pharmaceuticals;2024-03-04

5. Production of the state of the art therapeutic radiopharmaceuticals in Iran, from beta- to alpha-emitting targeted radionuclide therapy: Clinical advances and perspectives;IRAN J NUCL MED;2024